József Barkóczy

918 total citations
31 papers, 709 citations indexed

About

József Barkóczy is a scholar working on Organic Chemistry, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, József Barkóczy has authored 31 papers receiving a total of 709 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Organic Chemistry, 13 papers in Molecular Biology and 13 papers in Cellular and Molecular Neuroscience. Recurrent topics in József Barkóczy's work include Neuroscience and Neuropharmacology Research (12 papers), Synthesis and Characterization of Heterocyclic Compounds (10 papers) and Synthesis and biological activity (9 papers). József Barkóczy is often cited by papers focused on Neuroscience and Neuropharmacology Research (12 papers), Synthesis and Characterization of Heterocyclic Compounds (10 papers) and Synthesis and biological activity (9 papers). József Barkóczy collaborates with scholars based in Hungary, France and United States. József Barkóczy's co-authors include László G. Hársing, György Lévay, István Gacsályi, Michael Spedding, George R. Pettit, Gábor Szénási, József Reiter, Jayaram K. Srirangam, Michael D. Williams and Gábor Gigler and has published in prestigious journals such as Brain Research, Journal of Medicinal Chemistry and The Journal of Organic Chemistry.

In The Last Decade

József Barkóczy

29 papers receiving 684 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
József Barkóczy Hungary 16 292 264 176 96 74 31 709
Che‐Chang Hsu United States 14 460 1.6× 310 1.2× 170 1.0× 27 0.3× 47 0.6× 18 877
Raymond S. Gross United States 18 391 1.3× 112 0.4× 433 2.5× 37 0.4× 44 0.6× 35 907
Eric Vieira Switzerland 18 825 2.8× 542 2.1× 430 2.4× 30 0.3× 73 1.0× 25 1.4k
R.K. Somvanshi Canada 19 405 1.4× 192 0.7× 414 2.4× 16 0.2× 172 2.3× 47 1.2k
Philip A. S. Lowden United Kingdom 14 966 3.3× 527 2.0× 227 1.3× 65 0.7× 196 2.6× 23 1.4k
Manuel de Lera Ruiz United States 9 535 1.8× 180 0.7× 123 0.7× 15 0.2× 62 0.8× 14 828
Ji-Young Mun South Korea 14 272 0.9× 81 0.3× 75 0.4× 20 0.2× 40 0.5× 52 677
Anjana Sinha United States 14 391 1.3× 144 0.5× 300 1.7× 44 0.5× 90 1.2× 22 1.2k
Tinh N. Luong United States 11 631 2.2× 170 0.6× 173 1.0× 9 0.1× 71 1.0× 14 1.1k
Nicolas Girard France 18 446 1.5× 209 0.8× 468 2.7× 12 0.1× 55 0.7× 57 1.2k

Countries citing papers authored by József Barkóczy

Since Specialization
Citations

This map shows the geographic impact of József Barkóczy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by József Barkóczy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites József Barkóczy more than expected).

Fields of papers citing papers by József Barkóczy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by József Barkóczy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by József Barkóczy. The network helps show where József Barkóczy may publish in the future.

Co-authorship network of co-authors of József Barkóczy

This figure shows the co-authorship network connecting the top 25 collaborators of József Barkóczy. A scholar is included among the top collaborators of József Barkóczy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with József Barkóczy. József Barkóczy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Spedding, Michael, C. Sebban, Thérèse M. Jay, et al.. (2022). Phenotypical Screening on Neuronal Plasticity in Hippocampal-Prefrontal Cortex Connectivity Reveals an Antipsychotic with a Novel Profile. Cells. 11(7). 1181–1181. 4 indexed citations
2.
Mihalik, Balázs, P. Várga, Adam R. Brown, et al.. (2017). Selective inhibition of extra-synaptic α5-GABA A receptors by S44819, a new therapeutic agent. Neuropharmacology. 125. 353–364. 42 indexed citations
3.
Mihalik, Balázs, Ferenc Bogár, József Barkóczy, et al.. (2017). Loop-F of the α-subunit determines the pharmacologic profile of novel competitive inhibitors of GABA A receptors. European Journal of Pharmacology. 798. 129–136. 8 indexed citations
4.
Gacsályi, István, Gábor Gigler, Katalin Nagy, et al.. (2017). Behavioural pharmacology of the α5-GABA A receptor antagonist S44819: Enhancement and remediation of cognitive performance in preclinical models. Neuropharmacology. 125. 30–38. 16 indexed citations
5.
Gacsályi, István, Katalin Nagy, György Lévay, et al.. (2012). Egis-11150: A candidate antipsychotic compound with procognitive efficacy in rodents. Neuropharmacology. 64. 254–263. 13 indexed citations
6.
Nagy, Katalin, G. Zsilla, Péter Mátyus, et al.. (2010). Alterations in Brain Extracellular Dopamine and Glycine Levels Following Combined Administration of the Glycine Transporter Type-1 Inhibitor Org-24461 and Risperidone. Neurochemical Research. 35(12). 2096–2106. 21 indexed citations
7.
Gacsályi, István, Hajnalka Kompagne, László G. Hársing, et al.. (2008). Antagonism of AMPA receptors produces anxiolytic-like behavior in rodents: Effects of GYKI 52466 and its novel analogues. Psychopharmacology. 198(2). 231–241. 33 indexed citations
8.
Szénási, Gábor, Tamás Szabó, Mihály Albert, et al.. (2007). 2,3-Benzodiazepine-type AMPA receptor antagonists and their neuroprotective effects. Neurochemistry International. 52(1-2). 166–183. 34 indexed citations
9.
Gigler, Gábor, Mihály Albert, Mihály Végh, et al.. (2007). Neuroprotective and anticonvulsant effects of EGIS‐8332, a non‐competitive AMPA receptor antagonist, in a range of animal models. British Journal of Pharmacology. 152(1). 151–160. 17 indexed citations
10.
11.
Gressèns, Pierre, Michael Spedding, Gábor Gigler, et al.. (2005). The effects of AMPA receptor antagonists in models of stroke and neurodegeneration. European Journal of Pharmacology. 519(1-2). 58–67. 30 indexed citations
12.
Hársing, László G., et al.. (2004). A 5-HT7 Heteroreceptor-Mediated Inhibition of [3H]Serotonin Release in Raphe Nuclei Slices of the Rat: Evidence for a Serotonergic–Glutamatergic Interaction. Neurochemical Research. 29(8). 1487–1497. 47 indexed citations
13.
Dang, Long H., Chetan Bettegowda, Nishant Agrawal, et al.. (2004). Targeting Vascular and Avascular Compartments of Tumors withC. novyi-NTand Anti-microtubule Agents. Cancer Biology & Therapy. 3(3). 326–337. 80 indexed citations
14.
Gigler, Gábor, et al.. (2004). Comparison of the AMPA Antagonist Action of New 2,3-Benzodiazepines in Vitro and Their Neuroprotective Effects in Vivo. Pharmaceutical Research. 21(2). 317–323. 13 indexed citations
15.
Gigler, Gábor, et al.. (2004). Reduction of cerebral infarct size by non-competitive AMPA antagonists in rats subjected to permanent and transient focal ischemia. Brain Research. 1019(1-2). 210–216. 27 indexed citations
16.
Pettit, G.R., Jayaram K. Srirangam, József Barkóczy, et al.. (1998). Antineoplastic agents 365. Dolastatin 10 SAR probes.. PubMed. 13(4). 243–77. 52 indexed citations
17.
Reiter, József & József Barkóczy. (1997). On triazoles XXXVIII. The reaction of isomeric 5‐amino‐3‐morpholino‐1H‐1,2,4‐triazolylcarbothiohydrazides with ortho esters. Journal of Heterocyclic Chemistry. 34(5). 1575–1580. 1 indexed citations
18.
Pettit, George R., Sheo B. Singh, Delbert L. Herald, et al.. (1994). The Dolastatins. 17. Synthesis of Dolaproine and Related Diastereoisomers. The Journal of Organic Chemistry. 59(21). 6287–6295. 53 indexed citations
19.
Barkóczy, József & József Reiter. (1993). On triazoles XXX. Synthesis of [1,2,4]triazolo‐[1,5‐d][1,2,4,6]tetrazepine‐5‐thiones. Journal of Heterocyclic Chemistry. 30(4). 1009–1018. 4 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Che‐Chang Hsu Breakdown of academic impact, for papers by Raymond S. Gross Breakdown of academic impact, for papers by Eric Vieira Breakdown of academic impact, for papers by R.K. Somvanshi Breakdown of academic impact, for papers by Philip A. S. Lowden Breakdown of academic impact, for papers by Manuel de Lera Ruiz Breakdown of academic impact, for papers by Ji-Young Mun Breakdown of academic impact, for papers by Anjana Sinha Breakdown of academic impact, for papers by Tinh N. Luong Breakdown of academic impact, for papers by Nicolas Girard
Rankless by CCL
2026